| Company Name: |
Chemsky (shanghai) International Co.,Ltd
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:Acetyl-(Tyr1,D-Phe2)-GRF (1-29) aMide (huMan);Ac-Tyr-D-Phe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2;Acetyl-(Tyr1,D-Phe2)-SerMorelin
CAS:93965-89-0
Purity:99% Package:0.5Mg
|
|
| | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)- Basic information |
| Product Name: | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)- | | Synonyms: | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)-;Acetyl-(Tyr1,D-Phe2)-SerMorelin;Acetyl-(D-Phe2)-GRF (1-29) amide (human);Acetyl-(D-Phe2)-GRF (1-29) amide (human) trifluoroacetate salt Ac-Tyr-D-Phe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 trifluoroacetate salt;13:PN:WO2009031916 PAGE:7 claimed protein;1-29-Somatoliberin (human pancreatic islet), N-acetyl-2-D-phenylalanine-29-L-argininamide-;1-29-Somatoliberin (human pancreatic islet);Acetyl-(D-Phe2)-Sermorelin | | CAS: | 93965-89-0 | | MF: | C157H252N44O43S | | MW: | 3476.02 | | EINECS: | | | Product Categories: | | | Mol File: | 93965-89-0.mol |  |
| | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)- Chemical Properties |
| density | 1.44±0.1 g/cm3(Predicted) | | storage temp. | Desiccate at -20°C | | form | Powder | | Water Solubility | Soluble to 2 mg/ml in water | | Sequence | Ac-Tyr-{d-Phe}-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)- Usage And Synthesis |
| Description | VIP receptor antagonist; inhibits [125I]iodo-VIP binding and selectively inhibits VIP- and GRF-induced effects on adenylyl cyclase. | | Uses | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist[1]. | | References | [1] Waelbroeck M, et al. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology. 1985 Jun;116(6):2643-9. DOI:10.1210/endo-116-6-2643
[2] Dufes C, et al. Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro. J Mol Neurosci. 2003;21(2):91-102. DOI:10.1385/JMN:21:2:91 |
| | somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)- Preparation Products And Raw materials |
|